BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4556952)

  • 21. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid.
    Tosti A; Piraccini BM; Cameli N; Kokely F; Plozzer C; Cannata GE; Benelli C
    Br J Dermatol; 1998 Oct; 139(4):655-9. PubMed ID: 9892909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsoriatic activity of retinoic acid (vitamin A acid).
    Fredriksson T
    Dermatologica; 1971; 142(3):133-6. PubMed ID: 4939498
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
    Poulin Y
    Skin Therapy Lett; 2002 Jun; 7(6):1-3. PubMed ID: 12223976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New ointment with vitamin D derivative and corticoid. Psoriasis therapy combined].
    MMW Fortschr Med; 2003 Jan; 145(5):56. PubMed ID: 12619221
    [No Abstract]   [Full Text] [Related]  

  • 26. [A double-blind clinical trial of fluocinonide and betamethasone valerate in psoriasis].
    Feuerman E
    Harefuah; 1974 Jul; 87(2):59-60. PubMed ID: 4605470
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
    Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
    Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
    Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis.
    Satake K; Amano T; Okamoto T
    Eur J Pharmacol; 2018 May; 826():31-38. PubMed ID: 29476878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
    Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial.
    Christiansen JV; Foged E; Holm P; Jørgensen AS; Reymann F
    Dermatologica; 1985; 170(4):195-8. PubMed ID: 3888709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
    Vakirlis E; Kastanis A; Lazaridou E; Loannides D; Chrysomallis F
    Int J Clin Pharmacol Res; 2005; 25(4):165-8. PubMed ID: 16402632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris.
    Morita A; Muramatsu S; Kubo R; Ikumi K; Sagawa Y; Saito C; Torii K; Nishida E
    J Dermatolog Treat; 2018 Aug; 29(5):496-500. PubMed ID: 29076379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Betamethasone valerate ointment (Valisone).
    Med Lett Drugs Ther; 1969 Sep; 11(18):76. PubMed ID: 5820569
    [No Abstract]   [Full Text] [Related]  

  • 35. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 36. A double-blind trial of budesonide ointment and betamethasone-17-valerate ointment in psoriasis.
    Schmidt H; Hjorth N; Salde L
    J Int Med Res; 1981; 9(3):236-8. PubMed ID: 7016629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis.
    Hellgren L
    Ann Clin Res; 1976 Oct; 8(5):317-9. PubMed ID: 136921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A betamethasone-calcipotriene combination for psoriasis.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):55-6. PubMed ID: 16841023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse rate of psoriasis worsened by adding steroids to a dithranol regime.
    Seville RH
    Br J Dermatol; 1976 Dec; 95(6):643-6. PubMed ID: 795450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluocinonide compared with betamethasone in the treatment of eczema and psoriasis.
    Ronn HH
    Practitioner; 1976 Jun; 216(1296):704-6. PubMed ID: 781661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.